Pasithea Therapeutics Corp Share Price (NASDAQ: KTTA)

Pasithea Therapeutics Corp Stock Performance

as on October 3, 2025 at 12:37 am IST

Day's Low
Day's High
$0.75
Day's Price Range
$0.81
$0.79
5.06%
Downside
2.53%
Upside
52 Week's Low
52 Week's High
$0.65
52-Week Price Range
$5.45
$0.79
17.72%
Downside
589.87%
Upside

Pasithea Therapeutics Corp share price movements today

Previous Close: $0.77
Open: $0.76
Volume: 438.1K
Day's Low - High: $0.75 - $0.81
52 Week Low - High: $0.65 - $5.45

Pasithea Therapeutics Corp Historical Returns

1 Month Return: -14.38 %
3 Month Return: + 2.9 %
1 Year Return: -84.33 %
3 Year Return: -96.95 %
5 Year Return: 0 %

Pasithea Therapeutics Corp Stock Fundamentals & Key Indicators

Check Pasithea Therapeutics Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.4M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.31

Industry PE ratio

P/B Ratio

PEG Ratio

EBITDA

-13.1M

Revenue (TTM)

486.6K

Profit Margin

0.00%

Return On Equity TTM

3278500.00%

Pasithea Therapeutics Corp Stock Valuation

Track how Pasithea Therapeutics Corp P/E has moved over time to understand its valuation trends.

Pasithea Therapeutics Corp in the last 5 years

Overview
Trends

Lowest (-185.26x)

September 30, 2021

Industry (0.00x)

October 2, 2025

Today (-0.31x)

October 2, 2025

Highest (-0.14x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.31x

Pasithea Therapeutics Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pasithea Therapeutics Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Pasithea Therapeutics Corp	BUY	$5.4M	NA	-0.31	0.00%
Beone Medicines Ltd	NA	$37.9B	NA	NA	-3.89%
Alnylam Pharmaceuticals, Inc.	BUY	$59.8B	239.51%	-505.15	-12.96%
Vertex Pharmaceuticals Incorporated	BUY	$100.4B	54.99%	27.46	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.8B	6.22%	14.21	31.37%

Stock Returns calculator for Pasithea Therapeutics Corp Stock including INR - Dollar returns

The Pasithea Therapeutics Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Pasithea Therapeutics Corp investment value today

Current value as on today

₹21,760

Returns

₹78,240

(-78.24%)

Returns from Pasithea Therapeutics Corp Stock

₹83,910 (-83.91%)

Dollar Returns*

₹5,670 (+5.67%)

Analyst Recommendation on Pasithea Therapeutics Corp Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Pasithea Therapeutics Corp. Average target price of $2

Pasithea Therapeutics Corp Share Price Target

Get share price movements and forecasts by analysts on Pasithea Therapeutics Corp.

What analysts predicted

60.5%UPSIDE

Target Price

Current Price

$0.79

Analyzed by

7 Analysts

Target

$2.00

Pasithea Therapeutics Corp target price $2, a slight upside of 60.5% compared to current price of $0.79. According to 7 analysts rating.

Pasithea Therapeutics Corp Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	-	-	-	0	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-3	-3	-3	-5	-4	-3	-3	-3	-3	-3
EBITDA	-3	-3	-3	-4	-3	-3	-2	-3	-3	-3
Interest Expense	0	-	-	0	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-3	-3	-3	-5	-3	-3	-2	-3	-3	-3
Income Tax Expense	271	0	0	0	0	0	-	0	-	-
Net Income	-275	-3	-3	-5	-3	-3	-2	-3	-3	-3
Net Profit Margin	0.00%	0.00%	0.00%	-517.07%	0.00%	0.00%	0.00%	-489.60%	0.00%	0.00%

Pasithea Therapeutics Corp Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	0	-
Gross Profit	0	0	0	0
Operating Income	-4	-14	-15	-14
EBITDA	-4	-12	-15	-13
Interest Expense	0	0	-	-
Depreciation	0	0	0	0
Income Before Tax	-2	-13	-15	-13
Income Tax Expense	0	0	453	-
Net Income	-2	-13	-15	-13
Net Profit Margin	-14433.87%	-2683.43%	-3280.52%	0.00%

Pasithea Therapeutics Corp Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-3	-3	-5	-3	-3	-2	-3	-3	-3
Operating Cash Flow	-3	-2	-3	-4	-4	-3	-2	-3,055	-3
Investing Cash Flow	0	0	0	-	-	-	-	-	-
Financing Cash Flow	0	-4	0	-	-	4	0	1	5
Change in Cash	-3	-7	-3	-4	-4	1	-2	-1,581	1

Pasithea Therapeutics Corp Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-2	-13	-15	0
Operating Cash Flow	-3	-14	-13	0
Investing Cash Flow	0	-2	0	-
Financing Cash Flow	55	-3	-3	4,517
Change in Cash	52	-19	-16	-9,408

Global Institutional Holdings in Pasithea Therapeutics Corp

Funds	Holdings
AdvisorShares Investments, LLC	2.6%
Citadel Advisors Llc	0.63%
UBS Group AG	0.57%
LPL Financial Corp	0.13%
Hurley Capital, LLC	0.05%

See all

Insights on Pasithea Therapeutics Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.9% return, outperforming this stock by 153.0%
NO EFFECT
Against Peers
In the last 3 years, Beone Medicines Ltd has given 127.8% return, outperforming this stock by 224.9%
NEGATIVE IMPACT
Price Dip
In the last 1 month, KTTA stock has moved down by -18.6%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 976.30K → 649.02K (in $), with an average decrease of 33.5% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, -2.99M → -3.71M (in $), with an average decrease of 7.5% per quarter

About Pasithea Therapeutics Corp

Pasithea Therapeutics Corp. is a biotechnology company focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases. The Company is advancing a pipeline of three therapeutic product candidates, with a focus on its lead product candidate, PAS-004, a macrocyclic mitogen-activated protein kinase, or MEK inhibitor. PAS-004 is a small molecule allosteric inhibitor of MEK 1 and 2 (MEK 1/2) for potential use in the treatment of a range of RASopathies, including neurofibromatosis type 1 (NF1) and a number of oncology indications, among others. Its remaining two programs, PAS-001 and PAS-003, are in the earlier stages of development and are based on novel targets for the treatment of CNS disorders that it believes address limitations in the treatment paradigm of the indications it plans to address, which are amyotrophic lateral sclerosis (ALS) for its PAS-003 program, and schizophrenia for its PAS-001 program.

Organisation	Pasithea Therapeutics Corp
Headquarters	1111 Lincoln Road, Miami Beach, FL, United States, 33139
CEO	Dr. Tiago Reis Marques M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Pasithea Therapeutics Corp

Name	Title
Mr. Daniel H. Schneiderman	Chief Financial Officer
Dr. Lawrence Steinman BA, M.D., Ph.D.	Co-Founder, MD & Executive Chairman
Dr. Tiago Reis Marques M.D., Ph.D.	CEO & Director

FAQs

What is Pasithea Therapeutics Corp share price today?

Pasithea Therapeutics Corp share price today is $0.79 as on October 3, 2025 at 12:37 am IST. Pasithea Therapeutics Corp share today touched a day high of $0.81 and a low of $0.75.

What is the 52 week high and 52 week low for Pasithea Therapeutics Corp share?

Pasithea Therapeutics Corp share touched a 52 week high of $5.45 on October 4, 2024 and a 52 week low of $0.65 on August 8, 2025. Pasithea Therapeutics Corp stock price today i.e. October 3, 2025 at 12:37 am IST is trending at $0.79,which is 85.50% down from its 52 week high and 21.54% up from its 52 week low.

What is Pasithea Therapeutics Corp's market capitalisation today?

Pasithea Therapeutics Corp market capitalisation is $0.00T as on October 3, 2025 at 12:37 am IST.

How to invest in Pasithea Therapeutics Corp Stock (KTTA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Pasithea Therapeutics Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pasithea Therapeutics Corp Shares that will get you 1.8987 shares as per Pasithea Therapeutics Corp share price of $0.79 per share as on October 3, 2025 at 12:37 am IST.

What is the minimum amount required to buy Pasithea Therapeutics Corp Stock (KTTA) from India?

Indian investors can start investing in Pasithea Therapeutics Corp (KTTA) shares with as little as ₹88.689 or $1 (as of October 3, 2025 at 12:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹886.89 in Pasithea Therapeutics Corp stock (as per the Rupee-Dollar exchange rate as on October 3, 2025 at 12:43 am IST). Based on Pasithea Therapeutics Corp share’s latest price of $0.79 as on October 3, 2025 at 12:37 am IST, you will get 12.6582 shares of Pasithea Therapeutics Corp. Learn more about fractional shares .